{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:31:44Z","timestamp":1786444304628,"version":"build-2736575974"},"reference-count":26,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15770","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:32:15Z","timestamp":1784277135000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["\u00a0Establishment of extrahepatic bile duct cancer organoids using suspension culture and their application in clinical drug screening"],"prefix":"10.3892","volume":"32","author":[{"given":"Wei","family":"Huang","sequence":"first","affiliation":[{"name":"General Surgery Department, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730000, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhui","family":"Su","sequence":"additional","affiliation":[{"name":"General Surgery Department, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yu","sequence":"additional","affiliation":[{"name":"General Surgery Department, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pathology Department, Dingxi People's Hospital, Dingxi, Gansu 743000, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Zhejiang 310006, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wence","family":"Zhou","sequence":"additional","affiliation":[{"name":"General Surgery Department, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu 730000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"key20260811124548_b1-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: Cholangiocarcinoma: Current knowledge and future perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20260811124548_b2-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Ilyas","year":"2013","journal-title":"Gastroenterology"},{"key":"key20260811124548_b3-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1111\/liv.14093","article-title":"Anatomical, histomorphological and molecular classification of cholangiocarcinoma","volume":"39","author":"Kendall","year":"2019","journal-title":"Liver Int"},{"key":"key20260811124548_b4-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"607","DOI":"10.4251\/wjgo.v14.i3.607","article-title":"Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review","volume":"14","author":"Vij","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"key20260811124548_b5-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann Surg"},{"key":"key20260811124548_b6-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: Epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int"},{"key":"key20260811124548_b7-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","article-title":"Burden of digestive diseases in the united states part III: Liver, biliary tract, and pancreas","volume":"136","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"key20260811124548_b8-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: The next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20260811124548_b9-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/hep.31653","article-title":"Organoids and spheroids as models for studying cholestatic liver injury and cholangiocarcinoma","volume":"74","author":"Sato","year":"2021","journal-title":"Hepatology"},{"key":"key20260811124548_b10-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-019-0829-z","article-title":"Applications of patient-derived tumor xenograft models and tumor organoids","volume":"13","author":"Yoshida","year":"2020","journal-title":"J Hematol Oncol"},{"key":"key20260811124548_b11-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"key20260811124548_b12-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.copbio.2020.01.003","article-title":"Patient-derived xenografts (PDXs) as model systems for human cancer","volume":"63","author":"Invrea","year":"2020","journal-title":"Curr Opin Biotechnol"},{"key":"key20260811124548_b13-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3892\/ol.2022.13567","article-title":"Establishment of gastric cancer organoid and its application in individualized therapy","volume":"24","author":"Miao","year":"2022","journal-title":"Oncol Lett"},{"key":"key20260811124548_b14-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/pmic.200900758","article-title":"Matrigel: A complex protein mixture required for optimal growth of cell culture","volume":"10","author":"Hughes","year":"2010","journal-title":"Proteomics"},{"key":"key20260811124548_b15-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer -derived organoid cultures for disease modelling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat Med"},{"key":"key20260811124548_b16-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"e121490","DOI":"10.1172\/jci.insight.121490","article-title":"Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity","volume":"4","author":"Li","year":"2019","journal-title":"JCI Insight"},{"key":"key20260811124548_b17-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.stem.2025.05.011","article-title":"An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer","volume":"32","author":"Li","year":"2025","journal-title":"Cell Stem Cell"},{"key":"key20260811124548_b18-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"e70033","DOI":"10.1111\/cpr.70033","article-title":"Scalable matrigel-free suspension culture for generating high-quality human liver ductal organoids","volume":"58","author":"Gong","year":"2025","journal-title":"Cell Prolif"},{"key":"key20260811124548_b19-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"e2507500122","DOI":"10.1073\/pnas.2507500122","article-title":"Invasin-functionalized PIC hydrogels enable long-term 3D culture of epithelial organoids","volume":"122","author":"Wijnakker","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20260811124548_b20-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrm3873","article-title":"Three-dimensional organotypic culture: Experimental models of mammalian biology and disease","volume":"15","author":"Shamir","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20260811124548_b21-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ctrv.2018.09.002","article-title":"Biliary tract cancer: State of the art and potential role of DNA damage repair","volume":"70","author":"Lamarca","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"key20260811124548_b22-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"key20260811124548_b23-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: Modelling the complexity of the tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"key20260811124548_b24-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-023-02653-w","article-title":"Newly developed 3D in vitro models to study tumor-immune interaction","volume":"42","author":"Mu","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"key20260811124548_b25-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"e40058","DOI":"10.1371\/journal.pone.0040058","article-title":"Integrating macrophages into organotypic co-cultures: A 3D in vitro model to study tumor-associated macrophages","volume":"7","author":"Linde","year":"2012","journal-title":"PLoS One"},{"key":"key20260811124548_b26-ol-32-3-15770","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","article-title":"Organoid modeling of the tumor immune microenvironment","volume":"175","author":"Neal","year":"2018","journal-title":"Cell"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:45:51Z","timestamp":1786441551000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7,17]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15770","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}